HomeCompareCBDS vs PLD

CBDS vs PLD: Dividend Comparison 2026

CBDS yields 6734.01% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CBDS wins by $1134331306620777.00M in total portfolio value
10 years
CBDS
CBDS
● Live price
6734.01%
Share price
$0.03
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1134331306620783.50M
Annual income
$1,102,135,506,365,417,000,000.00
Full CBDS calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — CBDS vs PLD

📍 CBDS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCBDSPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CBDS + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CBDS pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CBDS
Annual income on $10K today (after 15% tax)
$572,390.57/yr
After 10yr DRIP, annual income (after tax)
$936,815,180,410,604,500,000.00/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, CBDS beats the other by $936,815,180,410,600,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CBDS + PLD for your $10,000?

CBDS: 50%PLD: 50%
100% PLD50/50100% CBDS
Portfolio after 10yr
$567165653310395.00M
Annual income
$551,067,753,182,711,100,000.00/yr
Blended yield
97.16%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

CBDS
No analyst data
Altman Z
-66.5
Piotroski
3/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CBDS buys
0
PLD buys
0
No recent congressional trades found for CBDS or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCBDSPLD
Forward yield6734.01%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$1134331306620783.50M$6.50M
Annual income after 10y$1,102,135,506,365,417,000,000.00$5,256,436.18
Total dividends collected$1132171482533551.75M$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: CBDS vs PLD ($10,000, DRIP)

YearCBDS PortfolioCBDS Income/yrPLD PortfolioPLD Income/yrGap
1← crossover$684,101$673,400.67$11,255$555.24+$672.8KCBDS
2$43,785,619$43,053,631.23$13,062$1,018.59+$43.77MCBDS
3$2,622,207,874$2,575,357,261.36$15,903$1,926.67+$2622.19MCBDS
4$146,947,359,732$144,141,597,307.61$20,839$3,823.32+$146947.34MCBDS
5$7,706,421,362,649$7,549,187,687,735.55$30,464$8,166.08+$7706421.33MCBDS
6$378,250,714,282,047$370,004,843,424,012.75$52,054$19,457.30+$378250714.23MCBDS
7$17,377,416,622,186,412$16,972,688,357,904,620.00$109,886$54,188.93+$17377416622.08MCBDS
8$747,333,345,286,586,900$728,739,509,500,847,500.00$304,030$186,451.18+$747333345286.28MCBDS
9$30,089,532,948,940,880,000$29,289,886,269,484,240,000.00$1,166,125$840,813.32+$30089532948939.71MCBDS
10$1,134,331,306,620,783,600,000$1,102,135,506,365,417,000,000.00$6,504,190$5,256,436.18+$1134331306620777.00MCBDS

CBDS vs PLD: Complete Analysis 2026

CBDSStock

Cannabis Sativa, Inc., through its subsidiaries, primarily provides telemedicine online referral services for customers desiring medical marijuana cards in the United States. The company offers PrestoDoctor, an online telemedicine platform, which provides access to physicians for getting a medical marijuana recommendation using video conferencing technology. Its products under development include Lozenges for relief from throat irritation; Recover, a deep penetrating healing balm used to relieve pain for sore muscles, joints, arthritic, and back pain; Trauma Cream, a cream for blended infusion of cannabinoids and THC; Face Garden, an antioxidant moisturizing cream for the face; Body Garden, a moisturizing body lotion; and Lip Garden, an emollient balm. The company also offers Wild Earth Naturals and hi branded men's and women's fashion tee shirts and sweatshirts, as well as caps and coffee mugs through Website, wildearthnaturals.com; and holds intellectual property license for manufacture of medical marijuana edibles. It serves cannabidiol and marijuana industries. The company was formerly known as Ultra Sun Corporation and changed its name to Cannabis Sativa, Inc. November 2013. Cannabis Sativa, Inc. is based in Mesquite, Nevada.

Full CBDS Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this CBDS vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CBDS vs SCHDCBDS vs JEPICBDS vs OCBDS vs KOCBDS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.